This is a Validated Antibody Database (VAD) review about human RHD, based on 2 published articles (read how Labome selects the articles), using RHD antibody in all methods. It is aimed to help Labome visitors find the most suited RHD antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RHD synonym: CD240D; DIIIc; RH30; RHCED; RHDVA(TT); RHDel; RHPII; RHXIII; Rh4; RhDCw; RhII; RhK562-II; RhPI; blood group Rh(D) polypeptide; D antigen (DCS); RH polypeptide 2; Rh blood group C antigen; Rh blood group CE antigen; Rh blood group CcEe antigen; Rh blood group antigen Evans; Rh blood group, D anitgen; RhD antigen; RhD blood group antigen; RhD polypeptide; Rhesus blood group D antigen allele DIII type 7; Rhesus system D polypeptide; blood group antigen D; blood group protein RHD; rhesus D antigen; truncated Rh blood group D antigen; truncated RhD; truncated rhesus D; truncated rhesus blood group D antigen

Miltenyi Biotec
human recombinant (REA327)
  • flow cytometry; human; fig 6a
In order to investigate the protective effect of single domain camelid antibodies against botulinum neurotoxin, Miltenyi Biotec RHD antibody (Miltenyi Biotec, 130-104-818) was used in flow cytometry on human samples (fig 6a). Nat Commun (2017) ncbi
human recombinant (REA327)
  • flow cytometry; human; fig 4b
Miltenyi Biotec RHD antibody (Miltenyi Biotec, 130-104-819) was used in flow cytometry on human samples (fig 4b). Mol Ther Methods Clin Dev (2017) ncbi
Articles Reviewed
  1. Huang N, Pishesha N, Mukherjee J, Zhang S, Deshycka R, Sudaryo V, et al. Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin. Nat Commun. 2017;8:423 pubmed publisher
  2. Chang K, Smith S, Sullivan T, Chen K, Zhou Q, West J, et al. Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev. 2017;4:137-148 pubmed publisher